CVRX
Healthcare Medical DevicesCVRx, Inc.
$1.57
+0.03 +1.95% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 6, 2026, live at 9:34 AM ET | 1.57 |
Key Stats
Market Cap
41.83M
Avg Volume
893,469
EPS
-$1.97
52W High
$11.30
52W Low
$1.50
Div. Yield
0.0%
Analyst Ratings
Hold0
Str Buy
3
Buy
3
Hold
0
Sell
1
Str Sell
Valuation
Forward P/E
-0.84
P/B Ratio
2.10
P/S Ratio
0.68
EV/EBITDA
-0.76
EV/Revenue
0.59
Margins
Gross Margin 86.9%
Operating Margin (82.9%)
Net Margin (84.9%)
EBITDA Margin (78.2%)
Growth & Returns
Revenue Growth (YoY)
15.6%
Return on Equity
(133.4%)
Return on Assets
(28.7%)
Liquidity & Leverage
Current Ratio
8.04
Quick Ratio
6.65
Debt / Equity
2.98
Total Cash
64.59M
Total Debt
59.39M
About
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
www.barostim.com